epro-995x60.png
FEATURED ARTICLES
-
FDA's Draft Guidance On Bayesian Methods: Strategic Implications For Small Biotechs
The FDA draft guidance on Bayesian methodology represents a major validation of statistical innovation in clinical development. Jessica Cordes summarizes the latest from the FDA and offers advice for small biotechs.
-
How Regulatory Convergence Is Rewriting Clinical Data Management
Regulatory shifts toward structured, digital clinical trial protocols are reducing manual interpretation, enabling risk-based oversight, and supporting more efficient, transparent, end-to-end trial execution.
-
Sponsor-Provided Source Templates: Your Questions Answered
See how centralized eSource improves trial operations through faster startup, better data quality, and real‑time protocol guidance. An expert Q&A offers practical tips for sponsors, sites, and CROs.
WHITE PAPERS AND CASE STUDIES
-
The Next Era Of eCOA Is AI
Discover how AI is moving beyond the hype to streamline clinical study builds. Explore practical ways to automate protocol digitization and UAT scripts while preparing for future patient tools.
-
Streamline Data Capture And Automate EHR-To-EDC Data Transfer
Streamline clinical trials by automating data transfer from EHRs to EDCs. Reduce site burden, minimize manual entry errors, and accelerate timelines to get critical insights faster.
-
The Definitive Infrastructure For Modern Drug Development
Modernize clinical trials with AI-powered recruitment and automated EHR data capture to accelerate enrollment, improve data quality, and expand patient access across a global research network.
NEWS
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
- Exco InTouch Joins Critical Path Institute ePRO Consortium To Advance Electronic Data Capture In Clinical Trials
- ERT Expands Corporate Presence In Japan